Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
M Vasala, K Immonen, H Kautiainen & M Hakala. (2010) More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases. Scandinavian Journal of Rheumatology 39:6, pages 461-465.
Read now
Read now
Riitta Koivuniemi, Leena Paimela, Risto Suomalainen, Tom Törnroth & Marjatta Leirisalo-Repo. (2008) Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 15:4, pages 262-268.
Read now
Read now
Noriyuki Horiuchi, Yuri Kotani, Masaaki Koga, Manabu Yamada, Yoshiyasu Kobayashi & Takane Matsui. (2008) Experimental induction of amyloidosis by bovine amyloid fibrils in Sore Hock rabbits. Amyloid 15:2, pages 84-88.
Read now
Read now
Articles from other publishers (18)
Hassan Bassiouni, Ahmed El-Atrebi, Khaled Zaky & Hoda Abou-Gabal. (2019) Prevalence of Subclinical Amyloidosis in a Cross-sectional Study of Egyptian RA Patients without Proteinuria. Current Rheumatology Reviews 15:2, pages 162-167.
Crossref
Crossref
Amadeo Armando Rojas Armata, Beymar Arturo Inchausti Callahuara & Diego Valdo Salinas Pacheco. (2018) Efficacy of the clinical activity of rheumatoid arthritis using the scales DAS28 and HAQ-20 in relation to the BAIC semiological maneuver. MOJ Gerontology & Geriatrics 3:4.
Crossref
Crossref
Johan Bijzet, Ingrid I. van Gameren & Bouke P. C. Hazenberg. 2015. Amyloid and Related Disorders. Amyloid and Related Disorders
229
248
.
Ramón Díez, Magdalena Madero, Gerardo Gamba, Juan Soriano & Virgilia Soto. (2014) Renal AA Amyloidosis in Patients with Type 2 Diabetes Mellitus. Nephron Extra 4:2, pages 119-126.
Crossref
Crossref
Carmen García-Gómez, Josep Valverde, Joan M. Nolla, M. José Castro, Juan A. Gómez-Gerique, Emili Corbella & Xavier Pintó. (2012) Influencia de la inflamación y la presencia de amiloide sobre el metabolismo lipídico en pacientes con artritis reumatoide. Clínica e Investigación en Arteriosclerosis 24:5, pages 226-233.
Crossref
Crossref
Hajime Isomoto, Yasuhiro Kamo, Chun Chuan Chen & Kazuhiko Nakao. (2012) Clinical management of gastrointestinal amyloidosis. Open Journal of Gastroenterology 02:04, pages 155-162.
Crossref
Crossref
Mohamed Younes, Wided Korbaa, Adnène Moussa, Saoussen Zrour, Ismail Bejia, Mongi Touzi, Abdelfatteh Zakhama & Naceur Bergaoui. (2009) Prévalence de l’amylose infraclinique dans une population tunisienne de polyarthrite rhumatoïde. Revue du Rhumatisme 76:5, pages 417-423.
Crossref
Crossref
Mohamed Younes, Wided Korbaa, Adnène Moussa, Saoussen Zrour, Ismail Bejia, Mongi Touzi, Abdelfatteh Zakhama & Naceur Bergaoui. (2009) Prevalence of subclinical amyloidosis in Tunisian patients with rheumatoid arthritis. Joint Bone Spine 76:3, pages 254-259.
Crossref
Crossref
Ellen C. Ebert & Michael Nagar. (2008) Gastrointestinal Manifestations of Amyloidosis. The American Journal of Gastroenterology 103:3, pages 776-787.
Crossref
Crossref
I. Ben Ghorbel, M. Khanfir & M.H. Houman. (2004) Amylose rénale compliquant une maladie de Still de l'adulte. La Revue de Médecine Interne 25:9, pages 675-677.
Crossref
Crossref
Masaki Shimoyama, Akira Ohtahara, Hiroko Fukui, Tomohisa Okamura, Hideki Shimizu, Mika Miyamoto, Masahiro Yamawaki, Shin-ichi Taniguchi, Yoshihiko Ueda, Ichiro Hisatome & Chiaki Shigamasa. (2003) Acute Secondary Gastrointestinal Amyloidosis in a Patient with Rheumatoid Arthritis. The American Journal of the Medical Sciences 326:3, pages 145-147.
Crossref
Crossref
Naoki Mantani, Toshiaki Kogure, Yutaka Shimada, Shinya Sakai & Katsutoshi Terasawa. (2003) Possible Relationship Between AA Amyloidosis and Decreased Complements in Patients with Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 9:4, pages 281-282.
Crossref
Crossref
Emili G�mez-Casanovas, Raimon Sanmart�, Manel Sol�, Juan D. Ca�ete & Jos� Mu�oz-G�mez. (2001) The clinical significance of amyloid fat deposits in rheumatoid arthritis: A systematic long-term followup study using abdominal fat aspiration. Arthritis & Rheumatism 44:1, pages 66-72.
Crossref
Crossref
Otto Braun-Falco, Gerd Plewig, Helmut H. Wolff & Walter H. C. BurgdorfOtto Braun-Falco, Gerd Plewig, Helmut H. Wolff & Walter H. C. Burgdorf. 2000. Dermatology. Dermatology
1278
1288
.
K. Laiho, S. Tiitinen, A-M. Teppo, M. Kauppi & K. Kaarela. (1998) Serum C-reactive protein is rarely lost into urine in patients with secondary amyloidosis and proteinuria. Clinical Rheumatology 17:3, pages 234-235.
Crossref
Crossref
Hartmut Michels, Reinhold P. Linke, Deborah L. Shapiro & Harry Spiera. (2005) Development of amyloidosis as an unrecognized side effect of gold therapy: Comment on the article by Shapiro and Spiera. Arthritis & Rheumatism 39:11, pages 1932-1934.
Crossref
Crossref
Hisashi Hasegawa, Shin‐Ichi Nishi, Satoshi Ito, Takako Saeki, Takeshi Kuroda, Hideki Kimura, Takeshi Watababe, Masaaki Nakano, Fumitake Gejyo & Masaaki Arakawa. (2005) High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. Arthritis & Rheumatism 39:10, pages 1728-1732.
Crossref
Crossref
Bouke P.C. Hazenberg & Martin H. Van Rijswijk. (1994) Clinical and therapeutic aspects of AA amyloidosis. Baillière's Clinical Rheumatology 8:3, pages 661-690.
Crossref
Crossref